Trial intelligence / Profile preview

CD07805/47 Gel in Rosacea Erythema

NCT01174030Phase 2Completed

Sponsor
Galderma
Start
Aug 2010
Primary completion
Dec 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Onreltea in rosacea, sponsored by Galderma. Started Aug 2010; status: completed.

02

Drugs

Onreltea
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT01174030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01174030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call